Sched.com Conference Mobile Apps
DIA 2021 Virtual Global Annual Meeting
has ended
Create Your Own Event
DIA 2021 Virtual Global Annual Meeting
-
Saved To
My Schedule
Schedule
Simple
Expanded
Grid
By Venue
Speakers
Search
or browse by date + venue
00: Plenary
All
Session
01: ClinSafety-PV
All
Forum
Session
Tutorial
Workshop
02: ClinTrials -ClinOps
All
Forum
Session
Tutorial
Workshop
03: Data-Data Standards
All
Forum
Session
Tutorial
Workshop
04: MedAffairs-SciComm
All
Forum
Session
Tutorial
Workshop
05: Patient Engagement
All
Forum
Session
Workshop
06: PreClin Dev-EarlyPhaseCR
All
Forum
Session
07: ProjMgt-StrategicPlanning
All
Forum
Session
Workshop
08: RD Quality-Compliance
All
Forum
Session
Tutorial
Workshop
09: Regulatory
All
Forum
Session
Tutorial
10: RegCMC-Product Quality
All
Forum
Session
11: Statistics
All
Forum
Session
Workshop
12: Value-Access
All
Forum
Session
Workshop
13: ProfDevelopment
All
Forum
Session
Tutorial
Workshop
14: DIAmond
All
Forum
Session
15: Content Hubs
All
Workshop
16: Community Rounds
All
Forum
17: Posters
All
Poster Presentation
18: Networking Opportunities
All
Forum
19: Short Courses
All
Tutorial
20: Early Access Content
All
Forum
Session
21: InnovationTheaters
All
Session
22: Solution Circles
All
Session
23: Spotlight Symposia
All
Session
24: Lunch-and-Learn
All
Session
Beginner
Advanced
Beginner
Intermediate
Featured Topics
Artificial Intelligence
Collaboration
COVID-19 - Pandemic
Digital Technology
Diversity Equity and Inclusion
HTA
Innovative Trial Design
Novel Therapeutic Approaches
Patient Focused
Regulator Thinking
RWD-RWE
Special Populations
Student Programming
What's Next
menu
Menu
Schedule
Speakers
Search
Advarra
United States
ArisGlobal, LLC
United States
Bioclinica
United States
Castor
Netherlands
Certara
United States
CGI
United States
Clinipace
United States
Deloitte
United States
ERT
United States
Fortrea
United States
Generis
United States
Greenphire
United States
IQVIA
United States
Medable
United States
Merative
United States
Parexel
United States
Pharm-Olam, LLC
Pharm-Olam International, Ltd., United States
RWS
United States
UBC
United BioSource Corporation, United States
U
Unqork
United States
ZS
United States
Hocine Abid
Health Canada, Canada
National Manager, Regulatory Operations and Enforcement Branch
Virginia Acha
Merck Sharp & Dohme LLC, United Kingdom
AVP, Global Regulatory Policy
Laura Acosta
Anju Software, United States
Vice President of Product Management, eClinical
Shazia Ahmad
UBC, United States
Senior Director, Patient and Physician Services
Saeeduddin Ahmed
Consultant, United States
LA
Linda Akunne
FDA, United States
Chief, Project Management Staff, ORO, CDER
MA
Mario Alanis
Centre for Innovation in Regulatory Science (CIRS), United Kingdom
Senior Advisor
XG
Xabier GarcĂa De AlbĂ©niz
Research Triangle Institute HS, Spain
Director
DA
Demissie Alemayehu
Pfizer Inc, United States
Vice President, Biostatistics
SA
Salvatore Alesci
Beyond Celiac, United States
Chief Scientist and Strategy Officer
MA
Mo Ali
GlaxoSmithKline, United States
Vice President, Digital Analytics and Performance
Paul Aliu
Novartis Pharma AG, Switzerland
Head Global Governance Office, Chief Medical Office
AA
Albert Allen
Eli Lilly and Company, United States
Senior Medical Fellow, Pediatric Capabilities
Jeff Allen
Friends of Cancer Research, United States
President and Chief Executive Officer
Cecilia Almeida
FDA, United States
Regulatory Counsel, DMPD, Office of Medical Policy, CDER
DV
Derek van Amerongen
Humana of Ohio, United States
Vice President and Medical Director
Gaynor Anders
Labcorp Drug Development, United States
Senior Director, Patient Engagement Strategy, Innovation and Delivery
Dawn Anderson
Deloitte, United States
Managing Director, Life Sciences
Jonathan Andrus
Clinical Research IO (CRIO), United States
President and Chief Operating Officer
Richardae Araojo
FDA, United States
Associate Commissioner for Minority Health, Director, Office of...
Peter Arlett
European Medicines Agency, Netherlands
Head Data Analytics and Methods Task Force
Richard Arlow
Complion, United States
Founder and Chief Executive Officer
Mary Arnould
Astellas, United States
Director, Clinical Science Operations
DA
Denis Arsenault
Health Canada, Canada
Manager, Policy Development
Derk Arts
Castor, Netherlands
Founder & CEO
Adam Asare
Quantum Leap Healthcare Collaborative, United States
Chief Data Officer
Philippe Auvaro
CMIC HOLDINGS Co., Ltd./Orphan Pacific Inc, Japan
OrphanPacific, Inc., President, Representative Director
Julian Avendaño
Merck, Sharp & Dohme, Colombia
Medical Writer
MA
Moyra Aziz
Novartis Pharmaceutical Corporation, United States
Post-Doctoral Fellow
Indranil Bagchi
Novartis Oncology, United States
Senior Vice President and Head, Global Value and Access
Qian Bai
University of Macau, Macao
PhD Candidate
SB
Stuart Bailey
Biogen, United States
Vice President, Head of Analytics and Data Sciences
Bill Baker
Deloitte Consulting LLP, United States
Specialist Leader
Chris Baker
Parexel, United States
EVP, Global Head Parexel FSP
OB
Omer Baker
University of Southern California, United States
Regulatory Science Student Researcher
PB
Pamela Balcazar
FDA, United States
Health Scientist, Oncology Center of Excellence, OC
Brenda Baldwin
FDA, United States
Microbiologist/Primary Reviewer, OVRR/DVRPA, CBER
Matt Baldwin
Advance Research Associates, Inc (ARA), United States
Senior Biostatistician
Greg Ball
Global Vaccine Safety, Novavax, Inc., United States
Head of Safety Statistics
Robert Ball
FDA, United States
Deputy Director, Office of Surveillance and Epidemiology, CDER
Mariah Baltezegar
PPD, United States
Vice President & Head of Consumer Health and PPA Study Innovation
Nagesh Bandi
Merck & Co., Inc, United States
Executive Director
Anamitro Banerjee
FDA, United States
Branch Chief, ONDP, OPQ, CDER
TB
Terrell Baptiste
Gilead Sciences, Inc., United States
Associate Director, Regulatory Policy and Intelligence
Bart Barefoot
GlaxoSmithKline, United Kingdom
Senior Director, European Regulatory Policy
RB
Roger Barker
Cambridge University, United Kingdom
Professor, Department of Clinical Neurosciences
Debu Baruah
IQVIA, India
Business Title Mgr, Software Development
Debu Baruah
IQVIA, India
Business Title Manager, Software Development
J. Lynn Bass
BridgeBio, United States
Senior Director, Medical Science Liaisons
PB
Peter Basseches
Merck & Co., Inc, United States
Distinguished Scientist, Global Regulatory Affairs and Clinical Safety
Alison Bateman-House
NYU Grossman School of Medicine, United States
Assistant Professor, Division of Medical Ethics, Dept of Population...
Ashley Baxter
Greenphire, United States
Sr. Business Optimization Specialist
Steven Beales
WIRB-Copernicus Group (WCG)
Senior Vice President, Scientific and Regulatory Review
Emmanuel Belabe
ArisGlobal, United States
Associate Vice President, Safety
Graham Belgrave
Advanced Clinical, United Kingdom
SVP, European Operations
JD
Jan De Belie
Pharmaceutical Group of the European Union (PGEU), Belgium
Professional Affairs Advisor
Brooke Belk
Syneos Health, United States
Vice President, Program Strategy - Kinetic
Hayley Belli
New York University School of Medicine, United States
Assistant Professor
Jan Benedictus
RWS, Netherlands
Managing Director
Lindsay Bengtson
Optum, United States
Director, Health Economics and Outcomes Research
Nathan Bennett
UCB Biosciences, Inc., United States
Head of Biostatistics and Statistical Programming, Rare Disease
Jeffrey Beno
CGI, United States
Director of Consulting, Emerging Technologies Practice
Robyn Bent
FDA, United States
Director, Patient Focused Drug Development Program, OCD, CDER
Lisa Bercu
FDA, United States
Regulatory Counsel, Office of Generic Drug Policy
Nathalie Bere
European Medicines Agency, Netherlands
Patient Engagement
Aaron Berger
UBC, United States
Head of Evidence Development Solutions
BB
Barry Berger
Former Professor of Regulatory Affairs, Temple University, United States
Retired
MB
Mitchell Berger
HHS, United States
Public Health Advisor
KB
Kiera Berggren
Virginia Commonwealth University, United States
Research Speech-Language Pathologist, Department of Neurology
Michael Berntgen
European Medicines Agency, Netherlands
Head of Scientific Evidence Generation
Scott Berry
Berry Consultants LLC, United States
President and Senior Statistical Scientist
Amy Bertha
Bayer, United States
Executive Director, Regulatory Policy and Innovation
Anil Bhojwani
Eli Lilly and Company, India
Sr. Manager (Sr Group Lead), Global Clinical Communication
Mark Birse
Parexel International, United Kingdom
Vice President, Technical
Kamal Biswas
Xybion Corporation, United States
President
Claire Blanchette
Consultant, United States
Executive Drug Development Program Leader
Michael Blum
FDA, United States
Deputy Director, Office of Pharmacovigilance and Epidemiology, CDER
Ashley Boam
FDA, United States
Director, Office of Policy for Pharmaceutical Quality, OPQ, CDER
MB
Mark Boaz
Pfizer Inc, United States
Senior Director, Pfizer Vaccines Research and Development
Winona Rei Bolislis
Sanofi, France
Regulatory Science and Policy Manager
Claire Bonaci
Microsoft, United States
Senior Director, US Health and Life Sciences
MB
Matthew Bonam
AstraZeneca, United Kingdom
Global Head, BioPharma R&D Digital Health
Barbara Bonetti
Pfizer Inc, United States
Director, Medical Customer Interface
CB
Christopher Boone
AbbVie, United States
Vice President, Global Head, Health Economics and Outcomes Research
Donna Booth
GlaxoSmithKline, United States
Director, Field Medical HTA and Policy, US Medical Affairs
David Borasky
WCG IRB, United States
Vice President, IRB Compliance
Poonam Bordoloi
Organon & Co., United States
Executive Director, Head of Global Medical Affairs Capabilities
Susan Bornstein
Pfizer Inc, United States
Senior Director, Data Monitoring/ Management, Clinical Sciences and...
DB
David Boulton
AstraZeneca, United States
Clinical Pharmacology and Quantitative Pharmacology Head of Post...
AB
Ariel Bourla
Flatiron Health, United States
Medical Director
Linda Bowen
Seagen Inc., United States
Head of Global Regulatory Policy and Intelligence
Adam Bowers
Bowers Content Studio, United States
Patient and Independent Consultant
David Bowers
PPD, United States
Senior Director, Operations
MB
Mark Bowlby
Synchrogenix, A Certara Company, United States
Director, Global Submissions
Amanda Kirby Bowles
Deloitte, United States
Managing Director
Kristina Bowyer
Ionis Pharmaceuticals, Inc., United States
Vice President, Patient Advocacy & Engagement
DB
Donna Boyce
Pfizer Inc, United States
Vice President, Global Regulatory Affairs, Vaccines
Nadia Bracken
GCP Cafe, United States
Chief Experience Officer
Brian Bradbury
Amgen, United States
Vice President, Center for Observational Research
Walker Bradham
IBM Watson Health, United States
Lead Product Manager
Dieter Brazel
CSL Behring GmbH, Germany
Senior Director, Technical and Strategic Area Lead, Plasma, GRA CMC
Lisbeth Bregnhoj
Danish Medicines Agency (DKMA), Denmark
Medicines Inspector, GCP
BB
Bonnie Brennan
Bayer, United States
Senior Director, Clinical Pharmacology Lead
Karl Broich
Federal Institute for Drugs and Medical Devices (BfArM), Germany
President
Philip (P.J.) Brooks
National Center for Advancing Translational Sciences (NCATS), NIH, United States
Deputy Director, Division of Rare Diseases Research Innovation
TB
Tori Brooks
Mapi Research Trust, United States
Research Associate II
Adam Brown
Clinark, United States
Founder and Chief Executive Officer
Elizabeth Brown
Merck & Co., Inc., United States
Principal Scientist/Managng Medical Writer
Viola Brown
Temple University, United States
Graduate Student
Annick De Bruin
CISCRP, United States
Senior Director, Research Services
Rachel Brunner
University of Illinois-Chicago, College of Pharmacy, United States
Drug Information Pharmacy Resident
Dyan Bryson
ICON, Supporting Janssen, United States
Global Strategic Solutions, Clinical Operations Lead, DEICT
James Buchanan
Covilance LLC, United States
President
Mandy Budwal-Jagait
Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
Head of GCP and Lead Senior GCP Inspector
Magda Bujar
Centre for Innovation in Regulatory Science (CIRS), United Kingdom
Senior Manager, Regulatory Programme and Strategic Partnerships
Kristin Bullok
Eli Lilly and Company, United States
Benefit-Risk Management Scientist, Global Patient Safety
Jason Bunting
FDA, United States
Science Policy Analyst, OCD, CDER
Victoria Burk
AbbVie, Inc.
Senior Director R&D Quality Assurance
LB
Leah Burns
Bristol-Myers Squibb Company, United States
Group Director, Real World Evidence Strategy
David Burrow
FDA, United States
Director, Office of Scientific Investigations, OC, CDER
Arianna Burton
Pfizer Inc, United States
Senior Manager, US Medical Affairs, Rare Disease
Matt Burtt
AbbVie, United States
Director Clinical QA
FB
Florence Butlen-Ducuing
European Medicines Agency, Netherlands
Senior Scientific Officer, Office of Therapies for Neurological and...
Renee Butler
Pharm-Olam, LLC, United States
Marketing Content Manager
Marc Buyse
IDDI, United States
Chief Scientific Officer
Tyler Bye
WCG ThreeWire, United States
Director, Program Strategy and Product Development
Bill Byrom
Signant Health , United Kingdom
Vice President, Product Intelligence and Positioning; Principal, eCOA...
Michelle Campbell
FDA, United States
Associate Director, Stakeholder Engagement and Clinical Outcomes, ON,...
Susan Cantrell
Academy of Managed Care Pharmacy (AMCP), United States
Chief Executive Officer
Melanie Carr
European Medicines Agency, Netherlands
Head of Stakeholders and Communication Division
Gillis Carrigan
Amgen, United States
Director, Center for Observational Research
Glenn Carroll
Deloitte, United States
Principal
Robyn Carson
AbbVie, United States
Vice President, Patient-Centered Outcomes Research
Elisa Cascade
ERT, United States
Executive Vice President, eCOA
John Cassidy
Labcorp Drug Development, United States
Global Head of Product and Commercial, Decentralized Clinical Trials
Nina Cauchon
Amgen, United States
Director Regulatory Affairs CMC
Nancy Cauwenberghs
Janssen R&D, Belgium
Head, Global Regulatory Affairs Vaccines
Marco Cavaleri
European Medicines Agency, Netherlands
Head of Health Threats and Vaccines Strategy
Patrizia Cavazzoni
FDA, United States
Director, Center for Drug Evaluation
Delaine Ceholski
Merck & Co., Inc., United States
Senior Specialist, Global Project and Alliance Management
Meghana Chalasani
FDA, United States
Lead, Advisory Committees, Office of New Drugs, CDER
Lisa Chamberlain-James
Trilogy Writing & Consulting, United Kingdom
Senior Partner
Andrew Chang
Novo Nordisk, Inc., United States
Vice President, Quality and Regulatory Compliance
IC
I-Fen Chang
Amgen, United States
Vice President, Head of Oncology Global Medical
Wendy Charles
Equideum Health, United States
Chief Ethics and Compliance Officer; Adjunct Faculty
Zina Chatzidimitriadou
Sidley Austin LLP, United Kingdom
Associate
Mamta Chawla
Consultant, India
WC
Wambui Chege
FDA, United States
Physician Policy Advisor, DMPD, OMP, CDER
Donny Chen
PPD, United States
VP Medical Writing and Healthcare Communications
Ta-Jen Chen
FDA, United States
Project Management Officer, OSP, CDER
Vatsal Chhaya
Genpro Research Inc, India
Senior Executive, Medical Writing and RWE
I-Shan Chiang
Labcorp Drug Development, United States
Senior Director, Market Development, DCT Center of Excellence
AC
Arturo Chiarella
Bristol-Myers Squibb Company , United States
Operations Portfolio Lead- Early Assets, Global Clinical Trial...
Karla Childers
Johnson & Johnson, United States
Head, Bioethics-Based Science and Technology Policy
CC
Costel Chirila
RTI International, United States
Director, Biostatistics
William Chong
FDA, United States
Associate Director for Clinical Affairs, Office of Generic Drugs, CDER
Girish Chopda
Dicerna Pharmaceuticals, United States
Associate Director, Nonclinical Development
Mads Christensen
LEO Pharma A/S, Denmark
R&D Project Manager
Leah Christl
Amgen, United States
Exec Director, Global Biosimilars Regulatory Affairs & Regulatory...
Jennifer Cichone
Otsuka Pharmaceutical Development and Commercialization Inc., United States
Director, GPV Strategic Management Office
R. Angelo De Claro
FDA, United States
Associate Director, Global Clinical Sciences, OCE; Div Dir, DHM, OOD,...
Chris Clendening
PPD, United States
Senior Vice President, PPD Laboratories Central Labs
Advanced Clinical
United States
CMIC Co., Ltd.
Catherine Cohet
European Medicines Agency, Netherlands
Pharmacoepidemiology Sr Spec, RWE Workstream, Data Analytics Methods...
Brian Cohn
ObvioHealth, United States
Director of Research
Deborah Collyar
Patient Advocates In Research (PAIR), United States
President
Medidata, a Dassault Systemes Company
United States
John Concato
FDA, United States
Associate Director for Real-World Evidence Analytics, OMP, CDER
LC
Laurie Conklin
Janssen, United States
Director, Pediatric Immunology
Jemma Contreras
Syneos Health, United States
Executive Managing Director, Advisory Group Lead
JC
Jenny Cook
Duke Clinical Research Institute, United States
Study and Project Engagement Specialist
Emer Cooke
European Medicines Agency, Netherlands
Executive Director, Chair, ICMRA
Freda Cooner
Eli Lilly and Company, United States
Senior Director - Statistics
Thomas Coquelle
LEO Pharma A/S, Denmark
Principal Clinical Project Manager
Andy Coravos
Elektra Labs, United States
Co-Founder, Chief Executive Officer
FC
Fiona Cornel
Health Canada, Canada
Acting Manager, Monoclonal Antibodies Division-Oncology, BRDD
Terri Cornelison
FDA, United States
Chief Medical Officer and Director for the Health of Women, CDRH
Microsoft Corporation
Microsoft Corporation, United States
1
2
3
4
5
6